Clearline Capital’s Acadia Healthcare ACHC Stock Holding History

Clearline Capital’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.52M	Sell	152,942 -95,884	-39%	-$2.46M	0.27%	70
2026 Q1	$5.82M	Buy	+248,826	New	+$4.5M	0.3%	63
2025 Q4	–	Sell	-571,497	Closed	-$14.2M	–	105
2025 Q3	$14.2M	Buy	571,497 +180	+0%	+$4.02K	0.65%	37
2025 Q2	$13M	Buy	+571,317	New	+$13.5M	0.48%	36
2024 Q4	–	Sell	-211,332	Closed	-$13.4M	–	95
2024 Q3	$13.4M	Buy	211,332 +45,816	+28%	+$3.31M	0.57%	31
2024 Q2	$11.2M	Buy	+165,516	New	+$11.6M	0.31%	34
2018 Q1	–	Sell	-89,992	Closed	-$2.94M	–	40
2017 Q4	$2.94M	Buy	+89,992	New	+$3.12M	1.52%	18

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Clearline Capital's ACHC Position: Q2 2026 in Review

Clearline Capital reduced its Acadia Healthcare (ACHC) stake by 39% in Q2 2026, selling an estimated $2.46M and leaving 152,942 shares worth $4.52M. The position accounts for 0.27% of the portfolio, ranked #70.

Clearline Capital first reported a position in ACHC in Q4 2017 and has held it in 7 quarters since. The position peaked at $14.2M in Q3 2025. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

Clearline Capital held 152,942 shares of Acadia Healthcare worth $4.52M as of Q2 2026.
Clearline Capital sold 95,884 Acadia Healthcare shares in Q2 2026, an estimated $2.46M.
Acadia Healthcare made up 0.27% of Clearline Capital's portfolio in Q2 2026, its #70 holding.
Clearline Capital first reported a position in Acadia Healthcare in Q4 2017 and has held it in 7 quarters since.
Clearline Capital's Acadia Healthcare position peaked at $14.2M in Q3 2025.
314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Clearline Capital's 13F filing for Q2 2026, filed 14 Aug 2026.